A Study of Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)
Status:
Completed
Trial end date:
2012-03-23
Target enrollment:
Participant gender:
Summary
This is a 2-part study in participants with renal impairment and matched healthy participants
to investigate the effect of impaired renal function on the plasma and urine levels of
omarigliptin (MK-3102) after taking a single 3 mg dose by mouth.